Thursday, November 7, 2024 at 12-1pm ET                        Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

The intent of evidence-based health care decision making is to compare all applicable and available treatment options. When direct comparisons from randomized controlled trials are not available, indirect treatment comparisons, including network meta-analyses, may offer valuable insights. In addition, mixed treatment comparisons, a type of network meta-analysis, combine both direct and indirect evidence for specific comparisons, providing a broader view than traditional network meta-analysis.

Learning Objectives

• Recognize the scientific relevance of ITCs and the level of rigor that they can provide, when adequately constructed, to the evaluation of population-based treatment decisions.
• Learn how ITCs can be leveraged to facilitate a robust evaluation of therapeutic options.
• Understand how ITCs can provide reliable evidence on the comparative efficacy and safety of a therapeutic option, which is essential for making informed clinical and economic decisions.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email media@amcp.org.